Clinical Trial Update: Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study [Phase 2]

View source ↗

Summary

This update describes an ongoing Phase 2 trial evaluating psilocybin for cannabis use disorder, currently recruiting at McMaster University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: McMaster University | Conditions: Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe | Phase 2 | Status: RECRUITING